Clinical Trials
11 trialsNCT05889390 2026-05-15
NeoHTerMa
Semmelweis University
Phase 2/3 Active not recruiting
NCT03609047 2026-05-12
Appalaches
European Organisation for Research and Treatment of Cancer - EORTC
Phase 2 Active not recruiting
NCT05959889 2026-03-09
Effect of Montelukast on Doxorubicin Induced Cardiotoxicity in Breast Cancer
Damanhour University
Phase NA Completed
NCT02096588 2024-07-09
Detection and Prevention of Anthracycline-Related Cardiac Toxicity With Concurrent Simvastatin
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 2 Terminated
NCT04248998 2023-01-18
BREAKFAST
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Phase 2 Unknown
NCT01057069 2022-10-12
neo-TN
The Netherlands Cancer Institute
Phase 2/3 Active not recruiting
NCT04243434 2020-04-16
PK Study on Ready-to-Use Injection (VSLI-RTU) 1 Vial & 3 Vial Formulation Marqibo® in Hematological Malignant Patients
Acrotech Biopharma Inc.
Phase 1 Unknown
NCT01329627 2014-05-21
TAME-01
Instituto do Cancer do Estado de São Paulo
Phase 2 Terminated
NCT00849472 2014-03-04
Treatment With Pazopanib for Neoadjuvant Breast Cancer
GlaxoSmithKline
Phase 2 Completed
NCT01917578 2013-08-06
BCSMANC
Shandong Cancer Hospital and Institute
Phase 3 Unknown
NCT01415336 2011-08-11
AX Versus AC as Adjuvant Treatment for Node-Negative Breast Cancer
Peking Union Medical College Hospital
Phase 2/3 Unknown